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High resolution peripheral quantitative computed tomography is a new technology com-
mercially available for <10 years that allows performing in vivo assessment of bone
parameters. High resolution peripheral quantitative computed tomography assesses the
trabecular thickness, trabecular separation, trabecular number and connectivity density
and,  in addition, cortical bone density and thickness and total bone volume and density
in  high-deﬁnition mode, which additionally allows obtaining digital constructs of bone
microarchitecture. The application of mathematics to captured data, a method called ﬁnite
element analysis, allows the estimation of the physical properties of the tissue, simulat-
ing  supported loads in a non-invasive way. Thus, high resolution peripheral quantitative
computed tomography simultaneously acquires data previously provided separately by
dual  energy X-ray absorptiometry, magnetic resonance imaging and histomorphometry,
aggregating biomechanical estimates previously only possible in extracted tissues. This
method has a satisfactory reproducibility, with coefﬁcients of variation rarely exceeding
3%. Regarding accuracy, the method shows a fair to good agreement (r2 = 0.37–0.97).
The main clinical application of this method is in the quantiﬁcation and monitoring of
metabolic bone disorders, more fully evaluating bone strength and fracture risk. In rheuma-
toid arthritis patients, this allows gauging the number and size of erosions and cysts, in
addition to joint space. In osteoarthritis, it is possible to characterize the bone marrow
edema-like areas that show a correlation with cartilage breakdown.
Given its high cost, high resolution peripheral quantitative computed tomography is still
a  research tool, but the high resolution and efﬁciency of this method reveal advantages over
the methods currently used for bone assessment, with a potential to become an importanttool in clinical practice.
© 2014 Elsevier Editora Ltda. All rights reserved.∗ Corresponding author.
E-mail: rosamariarp@yahoo.com (R.M.R. Pereira).
http://dx.doi.org/10.1016/j.rbre.2014.07.010
2255-5021/© 2014 Elsevier Editora Ltda. All rights reserved.
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Tomograﬁa  computadorizada  quantitativa  periférica  de  alta  resoluc¸ão
para  avaliac¸ão  de  parâmetros  morfológicos  e  funcionais  ósseos
Palavras-chave:
Tomograﬁa computadorizada
quantitativa periférica de alta
resoluc¸ão (HR-pQCT)
Parâmetros estruturais
Rádio
Tíbia
r  e  s  u  m  o
A tomograﬁa computadorizada quantitativa periférica de alta resoluc¸ão (HR-pQCT) é uma
nova tecnologia disponível comercialmente há menos de 10 anos que permite a feitura de
exames in vivo para a avaliac¸ão de parâmetros ósseos. A HR-pQCT avalia a forma, o número, o
volume, a densidade, a conectividade e a separac¸ão das trabéculas; a densidade e a espessura
do  osso cortical e o volume e a densidade total, em alta deﬁnic¸ão, o que permite a construc¸ão
digital da microarquitetura óssea adicionalmente. A aplicac¸ão de cálculos matemáticos aos
dados capturados, método denominado elemento ﬁnito (FE), permite a estimativa das pro-
priedades físicas do tecido e simula cargas suportadas de forma não invasiva. Desse modo,
a  HR-pQCT adquire simultaneamente dados antes fornecidos separadamente pela densit-
ometria óssea, pela ressonância magnética e pela histomorfometria e agrega estimativas
biomecânicas antes só possíveis em tecidos extraídos. A reprodutibilidade do método é sat-
isfatória, com coeﬁcientes de variac¸ão que raramente ultrapassam os 3%. Quanto à acurácia,
os  parâmetros apresentam de regular a boa concordância (r2 = 0,37–0,97).
A  principal aplicac¸ão clínica é na quantiﬁcac¸ão e no monitoramento das doenc¸as
osteometabólicas, porque avalia de modo mais completo a resistência óssea e o risco de
fratura. Na artrite reumatoide permite-se a aferic¸ão do número e do tamanho das erosões e
dos  cistos, além do espac¸o articular. Na osteoartrite é possível caracterizar as áreas edema-
símile que guardam correlac¸ão com a degradac¸ão da cartilagem.
Restritas ainda a um instrumento de pesquisa, dado o seu elevado custo, a alta resoluc¸ão
e  a eﬁciência mostram-se como vantagens em relac¸ão aos métodos atualmente usados para
a  avaliac¸ão óssea, com um potencial para tornar-se uma importante ferramenta na prática
clínica.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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soon became the gold standard for the evaluation of three-ntroduction
n the 1990s, the incorporation of dual energy X-ray absorp-
iometry (DXA) in clinical practice considerably boosted the
nowledge of metabolic bone diseases and the establishment
f fracture risk. However, bone strength also depends on tis-
ue microarchitecture. Thus, the histomorphometric analysis
as become necessary to supplement the bone evaluation,
nferring its spatial properties. But this is an invasive and
xpensive method that can only be performed from bone
amples.
In this scenario, a new in vivo method for assessing bone
icroarchitecture and volumetric bone mineral density (BMD)
n high-quality 3D emerges: high resolution peripheral quanti-
ative computed tomography (HR-pQCT). This technology was
riginally designed for the analysis of materials such as snow,
oncrete, gems, and so on. Subsequently, the technology came
o be used for the study of biological materials such as teeth,
mplants, bone and, more  recently, cartilage. In addition, the
ethod also allowed the analysis of biomechanical properties
f the analyzed material, with the use of a complex mathe-
atical process.
Its use for medical purposes has grown rapidly in recent
ears, because the method reveals in detail the internal struc-
ure of in vivo and ex vivo biological materials. The use of
R-pQCT is still largely conﬁned to the ﬁeld of scientiﬁc
esearch, given that there is less than half a hundred devices
orldwide in operation to perform the examination1 and onlytwo in Brazil. Due to its great potential, we  present here a
review of methodological aspects of HR-pQCT and its potential
clinical application.
What  is  HR-pQCT?
HR-pQCT is an imaging technique that uses computerized
processing of X-ray attenuation (measured in Hounsﬁeld
Units, HU) for the acquisition of sectional images, in the same
way that a conventional CT scan does. From the slices, it is pos-
sible to produce a three-dimensional (3D) high-quality model.
Although HR-pQCT is also often confused with Computed
Microtomography (MicroCT or CT), these terms are not syn-
onymous. While CT has a very high resolution of up to
fractions of m (micron) and evaluates in great detail the mor-
phology of the samples, its use is restricted to ex vivo analysis.2
On the other hand, HR-pQCT, speciﬁcally, is an equipment
whose resolution reaches only tens of micrometers; this size
is slightly larger than that represented by the trabecular struc-
ture, but also allows a detailed analysis of tissue morphology.
In addition, this method differentiates itself from CT as to
the possibility to perform rapid tests in vivo.3,4 The study
of bone structures with CT was introduced in 1989,5 anddimensional bone structure.
Currently, there is only one commercial HR-pQCT machine
that is able to perform scans at a resolution sufﬁcient to
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Fig. 1 – (A) Scanco XtremeCT HR-pQCT device. (B) Reference standardized planes for HR-pQCT. The dotted line indicates the
reference plane, while the solid lines indicate initial and ﬁnal planes of the test, comprising a thickness of 9.02 mm.  (C) The
sectional image of the leg, highlighting the tibial periosteum contour (in green). (D) The sectional image of the forearm,
struhighlighting the radial periosteum contour (in green). (E) Con
measure three-dimensional human bone microarchitecture
in vivo, the XtremeCT (SCANCO Medical AG, Brüttisellen,
Switzerland). (Fig. 1A). Nevertheless, the ability to measure the
average trabecular thickness is still limited by the maximum
resolution of the machine.6–8
Despite the ability to carry on morphological scanning of
the tissue microstructure, there was still no proper way to
estimate the mechanical properties of the material under
analysis in vivo. The improved resolution of 3D images pro-
vided by this new device coupled with computer-based ﬁnite
element analysis (FEA) modeling9 provides estimates of func-
tional properties of the material.
Image  acquisition  and  resultsThe standard test with XtremeCT evaluates distal radius and
tibia in vivo.10 The limb being scanned is immobilized in action of a 3D model of tibia, after initial analysis.
carbon ﬁber shell to avoid artifacts resulting from motion,
which could lead to the need for rescanning.11–13 Initially,
a scout view, essentially a two-dimensional X-ray scan,
is obtained to determine a precise region for the three-
dimensional measurement (Fig. 1B). Each site includes 110
computerized tomography slices, totaling an extension of
9.02 mm along the axial axis of the bone. The acquisition
of these images takes about 3 min. The standard proto-
col is typically conducted with the following settings: X-ray
tube current = 95 mA,  X-ray tube potential = 60 kVp, voxel
size = 82 m,  and a 1536 × 1536 matrix.
The HR-pQCT single-scan effective radiation dose is less
than 5 Sv.14 Some studies estimate that it is around 3 Sv
per measure.15 The international recommendation is that the
average annual dose for planned radiation exposure must not
exceed 20 Sv/year, measured over a deﬁned period of ﬁve
years.16,17 For comparison, a chest X-ray exposes to a radiation
dose of 20 Sv.
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Table 1 – HR-pQCT main bone parameters.
Abbreviation Parameter Description Unit
Structural parameters
BV/TV Bone volume ratio Ratio between bone volume
and total volume of tissue
–
Tb.N Trabecular number Mean number of trabeculae per mm
Tb.Th Trabecular thickness Mean thickness of trabeculae mm
Tb.Sp Trabecular separation Mean space between
trabeculae
mm
Tb.1/N.SD In homogeneity of network Standard deviation of the
inverse of number of
trabeculae
mm
Ct. Th Cortical thickness Average cortical thickness mm
Co.Po Cortical porosity Ratio between pore volume
and total cortical volume
–
Tt.Ar Total bone area Cross-sectional area mm2
Ct.Ar Cortical bone area Mean of the area occupied by
cortical bone
mm2
Tt.Ar Trabecular bone area Mean of the area occupied by
trabecular bone
mm2
Density parameters
BMD (D100) Bone mineral density Total volumetric density mg HA/cm3
Tb.BMD (Dtrab) Trabecular bone mineral density Trabecular volumetric density mg  HA/cm3
Dmeta Meta trabecular bone mineral density (40%) External trabecular volumetric
density (40% of trabecular
volume)
mg  HA/cm3
Dinn Inner trabecular bone mineral density (60%) Inner trabecular volumetric
density (60% of trabecular
volume)
mg  HA/cm3
Meta/Inn Ratio meta to inner bone mineral density Ratio between outer and inner
trabecular bone density
–
Ct.BMD (Dcomp) Cortical bone mineral density Cortical volumetric density mg  HA/cm3
p
(
a
n
i
i
p
a
d
c
e
t
t
t
m
p
t
l
c
a
t
b
o
lAfter the acquisition of images, the system automatically
erforms an initial evaluation that consists of two processes:
1) processing of digital data in sectional images (Fig. 1C and D)
nd (2) construction of a 3D model (Fig. 1E). Subsequently, it is
ecessary to determine the compartments. The ﬁrst contour
s characterized by the outer envelope of the radius, which
s then used to deﬁne the full compartment. The software is
rovided with a semiautomatic contouring algorithm (Fig. 1C
nd D).
After obtaining this contour, the next necessary step is to
etermine the inner contour delineating cortical from trabe-
ular bone, with the goal of obtaining isolated data relating to
ach of the compartments. This is a complex process, because
heir boundary is not always well deﬁned. Where the cor-
ex is rather thick or highly porous, the boundary between
he compartments may be inaccurate.18 This procedure auto-
atically creates the different compartments based on image
rocessing.19,20
Another aspect that must be established with respect to
rabecular bone is to describe and quantify the plate and rod-
ike structure of bone. While rod-like trabeculae have two
onnections (called disjunctive) attached to the adjacent bone
nd only one contact surface with the bone marrow, plate-like
rabeculae have only one contact surface with the adjoining
one (in all its perimeter) and two with the bone marrow (one
n each side of the disc).20 This process of rod-like and plate-
ike trabeculae separation is performed automatically by thesoftware, having an inﬂuence on the results of some of the
parameters.
A series of tests to determine the main bone parameters
used in the literature follows.1 Thus, mathematical algorithms
are required that allow such calculations. The manufacturer’s
software already includes computer scripts containing the
equations.
These scripts include the deﬁnition of bone volume, bone
volume density, structure model index, trabecular thickness,
trabecular separation, trabecular number and connectivity
density, and cortical thickness. The degree of cortical porosity
is the most relevant cortical data obtained. Table 1 discrimi-
nates the main parameters and their terminology, as used in
the medical literature.
Finite  element  analysis  modeling
FEA is a numerical technique of engineering, which, when
applied to medicine, allows a quantitative and qualita-
tive estimation of biomechanical properties resulting from
bone microarchitecture, by means of complex differential
equations.21–23After standard-data acquisition from microarchitecture,
the addition of the speciﬁc ﬁnite element analysis script
becomes possible, thus allowing the estimation of bone func-
tional properties from data collected in a static manner. The
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Fig. 2 – (A) Voxel conversion technique. In the scheme, each of the cubes to the right is a voxel with a speciﬁc elasticity, here
represented by different shades of gray. (B) Virtual compression test, performed by the ﬁnite element software. Application
of compressive forces (in yellow). (C) Illustration of Young’s modulus. The removal of the compression forces (in yellow)
causes the material to return to its original shape. (D) Example of the result of an analysis with the ﬁnite element method;
axial bone section. In red, areas subjected to greater stress; in green, areas under less stress.software employs the so-called “voxel conversion technique”
(Fig. 2A) to create ﬁnite element models (Finite Element Soft-
ware, V.1.13, Scanco Medical AG, Switzerland, January 2009
Manufacturer Handbook). In this technique, the vector infor-
mation obtained in the model is converted into blocks called
voxels, which have identical shape and size. The voxels are
shaped like cubes, being the smallest unit that makes up the
image  of the analyzed material. Each voxel is registered with
one among 255 gradations of elasticity recognized by the sys-
tem to perform the mathematical calculations. The standard
analysis of FEA comprises a virtual resistance test, namely, the
computer estimates and analyzes the behavior of the bone tis-
sue when it is submitted to a compressive force along its major
axis (Fig. 2B).
For analysis of FE, two mechanical properties of the
bone under study must be estimated, considering that
no histofunctional study of bone tissue is being carried
out:• The ﬁrst of them is the Young’s modulus, a measure of the
ability of a material to return to its original shape after
removal of a stress force, thus indicating the tissue’s elastic-
ity. This measure is valid only in the range of forces in which
the elastic deformation occurs, namely, when there is nei-
ther microrupture nor change in bone structure, enabling it
to return to its original form.
• The second mechanical property is a measure of the Pois-
son effect, which is the tendency of a material to become
thinner when it is stretched at a given axis. In other words,
when a material is pulled, it increases its size in the axis
of traction, and decreases its size in the other two  axes. In
response to the tensile force applied, the elasticity of the
material will tend to bring it to its original shape. This trend
can be understood as a force that will shrink the material
in the direction of its stretching and will increase it in the
other directions. The Poisson ratio is a ratio between the
ﬁrst and second forces.24
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Table 2 – Mechanical parameters obtained by Finite Element.
Abbreviature Parameter Description Unit
S Stiffness Tissue stiffness N/mm
F.ult Estimated ultimate failure load Estimate of maximum supported load N
(Tb.F/TF)dist – The ratio between the load supported by
trabecular bone and the load supported
by the whole bone, at its distal end
–
(Tb.F/TF)prox – The ratio between the load supported by
trabecular bone and the load supported
by the whole bone, at its proximal end
–
E.app Apparent modulus Apparent modulus (gauges stress) N/mm2
Tb.VM Trabecular Van Mises stress Trabecular stress (gauges pressure on
trabeculae)
N/mm2
C.VM Cortical Van Mises stress Cortical stress (gauges pressure on the
cortex)
N/mm2
Tb.ES Average equivalent strain
trabecular bone
Measures average trabecular deformation –
Ct.ES Average equivalent strain
cortical bone
Measures average cortical deformation –
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iThe values of these variables are not yet fully established,
nd hence their use varies according to the literature used.
he normal range of Young’s modulus used is between 10 GPa
nd 22.5 GPa (Giga Pascal is a multiple of the standard unit of
ressure in the international system, deﬁned as Newton/m2).
he Young’s modulus can be set separately for both trabecular
nd cortical bone. On the other hand, the Poisson ratio is 0.3
or most studies.25–30
The application of this technique has produced, in a simple
nd fast way, a huge amount of data, previously only obtained
rom invasive, costly and time-consuming procedures. These
re data that estimate the supported load and the deforma-
ions of the bone as a whole, and in each of its regions. Table 2
ists the main parameters obtained from this method.
ccuracy
he analyses of HR-pQCT accuracy are based on the gold
tandard for measurement of bone microarchitecture, the
CT. Comparisons are performed on cadaver data, mostly due
o the inability to perform in vivo tests with CT devices.
Overall, the parameters exhibit good to moderate agree-
ent (r2 = 0.37–0.97). It is noted, however, that some param-
ters such as BV/TV (r2 = 0.91–0.97)3,31 and Tb.Sp (r2 = 0.91)3
xhibited an excellent correlation, while parameters such as
b.1/N.SD (r2 = 0.62–0.71)4 and Tb.Th (r2 = 0.42–0.64)3,31 had a
ower correlation.
Tjong et al.3 also investigated the impact of different voxel
izes on HR-pQCT and its correlation with gold standard
arameters. Alternating between standardized values by
TremeCT (41 m;  82 m;  and 123 m),  it is possible to sig-
iﬁcantly change the accuracy. With a voxel of 123 m,
b.Th presents r2 = 0.37; increasing the resolution to 41 m
ne reaches r2 = 0.82. Similarly, Tb.Sp can vary from r2 = 0.78
2o r = 0.95. But some parameters, especially BMD, are lit-
le inﬂuenced by the increased resolution. Tb.BMD remains
t r2 = 0.84–0.85 in the various resolutions compared. While
mproving the accuracy, decreasing the voxel size implies in agreater examination time and, therefore, the chances of occur-
rence of artifacts resulting from patient motion are multiplied.
Total bone mineral density (D100), in addition to the other
BMD  parameters obtained with HR-pQCT, may also be com-
pared with those obtained by Dual energy X-ray densitometry
(DXA). It is important to note, however, that while HR-pQCT
and CT calculate volumetric densities (vBMD), DXA calcu-
lates density per area (aBMD). The correlation shown in the
comparison between HR-pQCT and DXA, depending on the
parameter analyzed, can vary from r2 = 0.37 to r2 = 0.73, being
maximum when the comparison is made between total vBMD
and aBMD.32 It can be noted, however, that there are still few
studies focused on showing the correlation between these
parameters.
Reproducibility
To date, few studies reporting the reproducibility of results
obtained by HR-pQCT were published. Most of these studies
show that the equipment, when used in accordance with stan-
dardized and well-deﬁned protocols, reaches low coefﬁcients
of variation. Several aspects inﬂuence the reproducibility of
results, among which stand out the parameter being analyzed,
the protocols used, the bone being evaluated and the correct
accomplishment of calibration protocols.
The parameters derived from HR-pQCT can be divided into
those concerning structural measures and those related to
BMD  (Table 1). Comparing the reproducibility, it can be noticed
that this factor is greater in the second versus ﬁrst group. While
the structural measures can achieve coefﬁcients of variation
of up to 3.2–4.4%, those relative to bone mineral density hardly
exceed 1%.33,34 The explanation for this fact is that, in the
evaluation of BMD, an average value of bone tissue concen-
tration by total volume is used, and this parameter is little
inﬂuenced by the small shape features. On the other hand,
structural measures vary signiﬁcantly with any change in the
acquisition angle, or with movement.
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As for the protocols employed, these must be very well
deﬁned, to improve reproducibility. They include: patient posi-
tioning, ﬁxing the limb into the support shell, and the choice of
the reference plane, among others. Basically, all these factors
can give rise to three types of errors: artifacts of movement,
reducing the overlap in different measurements, and changes
in angulation. The lack of a comfortable position and the non-
ﬁxation into the support shell can lead to patient motion,
which increases the variation between tests. The choice of the
reference plane (boundaries of bone area analyzed) can cause
signiﬁcant discrepancies in the results obtained33; in this mea-
surement, the change of only 1 mm can lead to a variety of
11% in the tissue sample analyzed. As to the bone evalu-
ated, according to Boutroy et al.34 in most cases the results
for the tibia have higher coefﬁcients of variation, when com-
pared to similar parameters for the radius. But MacNeil et al.33
observed that radius measurements are more  prone to move-
ment artifacts.
Regarding XtremeCT, it is important to note that the
proper conduct of daily and weekly calibration protocols was
extremely important for maintaining high standards of repro-
ducibility and low variability in the short and long term,
besides multicenter reproducibility.35
Applications
The use of HR-pQCT in biological tissues generated an enor-
mous range of possibilities for scientiﬁc research, and this can
be observed by the exponential increase in the number of pub-
lications that make use of this technology in recent years. The
functional analysis with the ﬁnite element method has further
expanded the number of applications of the technique.
Since its ﬁrst use for bone assessment, this has been
the main application of HR-pQCT. Studies indicate that it
is possible to evaluate the proﬁle of bone microarchitecture
throughout life, the risk of fractures, mineralization and the
development of bone diseases (e.g., osteoporosis). The effect of
drugs and diets in bone formation, resorption and morphology
also can be veriﬁed. Currently, the use of HR-pQCT has been
extended to the diagnosis and monitoring of inﬂammatory
arthropathies, such as rheumatoid arthritis and osteoarthri-
tis. However, the practical use of the method still seems much
more  promising for, and responds to gaps in, osteoporosis; in
osteoarthritis and rheumatoid arthritis, its usefulness is still
more  related to research.
The  use  of  HR-pQCT  in  osteoporosis  and
fracture  risk  assessment
Osteoporosis (OP) is characterized by a compromised bone
strength, predisposing the individual to the risk of fractures.36
Dual emission X-ray densitometry (DXA) is still the gold
standard for diagnosis, monitoring and clinical investigation
of the patient with osteoporosis.37 However, bone mineral
density (BMD) only corresponds to a part of bone strength.38Thus, for the assessment of fracture risk, BMD  measure-
ments should be associated with other factors that inﬂuence
bone strength: cortical thickness and porosity, trabecular
microstructure and bone geometry.39 These combined factors 0 1 5;5 5(4):352–362
contribute to deﬁne the biomechanical properties of bone tis-
sue, such as stiffness and supported load.31
The ability of HR-pQCT to deﬁne these parameters of bone
architecture, in conjunction with the ability of the FEA for esti-
mating biomechanical properties, makes this technique an
excellent tool for osteoporosis evaluation. It has been shown
by several studies that this data set is closely linked to the risk
of fractures in OP,10,22,40 and also that individuals with similar
results obtained by DXA may have large differences in fracture
risk, due to the above factors.41,42
The  use  of  HR-pQCT  in  monitoring  therapy
Some,43–46 but not all,47 studies suggest that changes in BMD
during the therapy of osteoporosis correlate to the reduction
in fracture risk. A meta-analysis of 12 clinical trials concluded
that a BMD improvement in the spine comprises only a small
part of the reduction in fracture risk.48 Thus, to evaluate the
therapeutic aspects, the use of parameters that measure not
only the BMD  is in order, but also the bone microarchitecture.
Several studies already published have demonstrated that
therapeutic treatments for osteoporosis can bring improve-
ment in many  bone parameters. Thus, HR-pQCT is a tool that
allows a much more  detailed assessment of treatment com-
pared with DXA.
Cheung et al.1 reported several studies on the use of HR-
pQCT in monitoring osteoporosis treatment. Research
conducted with alendronate,49–52 zoledronic acid,53
ibandronate,54,55 denosumab,51 strontium ranelate,49,50
odanacatib56,57 and teriparatide53,58 can demonstrate changes
mainly in the parameters of vBMD for the various bone com-
partments, cortical thickness, maximum supported load and
trabecular number.
The  use  of  HR-pQCT  in  rheumatoid  arthritis
Bone erosions are closely linked to the progression of rheuma-
toid arthritis (RA). Therefore, monitoring of these lesions is an
early prognostic parameter and an important input to mon-
itor the effectiveness of treatment.59,60 Currently, among the
imaging methods, conventional radiography is the most used
tool in clinical practice to aid in the diagnosis and mon-
itoring of RA for evaluating erosions and bone loss,61 but
besides being a semiquantitative procedure, the identiﬁcation
of lesions in this type of test takes 6–12 months to become
apparent.62
Stach et al.63 showed that it is possible to adapt the HR-
pQCT device for evaluating the volume of bone erosions.
This information is obtained by measuring distances in var-
ious directions in the slices made.64,65 The current analysis
method is still not automated nor standardized, but prelimi-
nary results of some studies show that the high-resolution of
HR-pQCT allows a precise characterization of bone erosions
61on a much greater degree of detail than traditional methods.
The technique also allows the evaluation of the joint space of
metacarpophalangeal and proximal interphalangeal joints,66
an important parameter in the evaluation of RA.
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Recent studies show that the data obtained with HR-
QCT in patients with RA have a higher sensitivity, when
ompared to data obtained by conventional radiographs in
orrelation with markers of bone catabolism and anabolism
r = 0.393–0.474).67 This shows that HR-pQCT can not only eval-
ate momentarily RA, but also show disease progression.
he  use  of  HR-pQCT  in  osteoarthritis
n osteoarthritis (OA), a cartilage lesion is accompanied by
lterations in subchondral bone and marrow space. Magnetic
esonance imaging can connect cartilage injury to regions
here there are the so-called bone marrow edema-like (BMEL)
njuries, which are areas of high signal on T2-weighted
mages.68 In these places it is possible to observe, in addi-
ion to edema, necrosis of adipocytes, increase of ﬁbrous tissue
nd an accelerated bone metabolism. However, the magnetic
esonance is unable to determine which changes in bone
icroarchitecture are present, and how they relate to disease.
There are still few studies demonstrating the efﬁcacy
f assessment with HR-pQCT in the diagnosis and progno-
is of OA, but Kazakia et al.69 demonstrated that, in BMEL
njuries, important changes occur in some bone parameters.
hese authors69 evaluated fragments of subchondral bone of
he tibia in patients treated with knee arthroplasty due to
steoarthritis. They found that there was a signiﬁcant increase
n volumetric bone mineral density (vBMD) and bone vol-
me/total volume (BV/TV), along with trabecular thickening
Tb.Th). Also in this study, when data obtained with HR-pQCT
ere coupled to the bone spectroscopic analysis, a reduction
n the mineral/matrix ratio was noted. In fact, histological
valuations reveal that, in these BMEL areas, an inﬁltration
f marrow spaces by a ﬁbrous collagen network and intense
one remodeling occur. The relationship between these bone
hanges with cartilage damage is not yet fully known. It is
ossible that the measurement of these data may have an
mportant clinical role in OA.
erspectives
lthough HR-pQCT has been launched on the market less than
0 years ago, this technology has already a myriad of medi-
al applications. Groups of researchers worldwide have been
orking to ﬁnd new ways to exploit its full potential. For now,
he device is still a tool restricted to research; but considering
he things it has been able to assess, the underlying view is
hat, in a short time, HR-pQCT will become an important clin-
cal tool. However, the current costs are still an obstacle to its
ull clinical use.
Its high resolution and non-invasive characteristics, the
valuation in vivo, and its speed and efﬁciency are advan-
ageous points over traditional methods of measuring bone
ineral density and histomorphometry for bone studies.
hus, HR-pQCT can be used for an efﬁcient and accurate
ssessment of the development of diseases such as osteo-
orosis, osteoarthritis and rheumatoid arthritis. Thus, in the
uture, the incorporation of the measurements of this tech-
ology on classiﬁcation criteria and in the staging of various 5;5 5(4):352–362 359
clinical conditions may occur. It will be absolutely essential to
carry out further studies on safety, accuracy and reproducibil-
ity of the analyses promoted by HR-pQCT in various diseases
and in the aging process, when compared to what is already
established by CT, DXA and histomorphometry.
It will be important also to determine and consolidate the
standards of normality for different populations. Some stud-
ies using control groups for comparison have been published,
but there is still not one comprehensive study in this direction
for the Brazilian population. Presently, the study group at the
Laboratory for Bone Metabolism, Medicine School, Universi-
dade de São Paulo (LIM-17) is conducting a study to determine
normality curves for HR-pQCT and Finite Element Analysis
parameters with a sample of over 400 healthy women aged
over 20 years.
At this point, it is worth mentioning some limitations of
the assessments performed with HR-pQCT and in the appli-
cation of ﬁnite element analysis modeling. One of them is
that the achievement of parameters of strength and stiffness
depends on functional estimates and on the application of
mathematical models that, in many  cases, are not entirely
reliable representations of reality. Moreover, it is not yet really
clear how the morphofunctional changes observed in periph-
eral bones (radius and tibia) may correlate with the rest of
the skeleton. Another limitation to be emphasized is related
to the resolution of the device that, despite being the high-
est available today for testing in vivo, is not still sufﬁcient to
individually assess trabeculae.
Finally, it is necessary to consolidate the standardization
of methods of acquisition and analysis of images with HR-
pQCT technology. To do so, one must keep in mind the patient
positioning, system settings, the initial and ﬁnal planes of
imaging for the site measurements and the most important
parameters in the various assessments. Regarding ﬁnite ele-
ment analysis modeling (which only recently is being used in
bone studies), it is really important to deﬁne patterns of bone
functional properties (Young’s modulus and Poisson’s ratio).
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